Market Cap 160.79M
Revenue (ttm) 4.06M
Net Income (ttm) -50.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,236.95%
Debt to Equity Ratio 0.00
Volume 288,400
Avg Vol 339,796
Day's Range N/A - N/A
Shares Out 32.29M
Stochastic %K 81%
Beta 1.63
Analysts Sell
Price Target $8.33

Company Profile

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The compa...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 949 409 7600
Address:
2 International Plaza Dr., Suite 510, Nashville, United States
Bogwood
Bogwood May. 14 at 3:34 AM
$IMDX Not a single IQ sale this past Q 🤢🤮 At least the letter highlights that 2Q will be great, but wow we need to hope the FDA can keep the August date
0 ¡ Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 9:26 PM
$IMDX Q1 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. anticipates continued operating losses and negative operating cash flows for the foreseeable future, though management believes it has sufficient cash to meet projected operating requirements for at least the next twelve months.
0 ¡ Reply
jackedmund99
jackedmund99 May. 5 at 5:52 PM
$IMDX Refinitiv/Verus is a high-performing, quantitative independent research firm- this clown firm put a sale on Stock yesterday while it was going up a dollar it’s a quantitative research company. They have no foresight no intuition. They look at everything from quantitative analytical viewpoint obviously not doing a deep dive not talking to anybody just purely odd numbers so in the grand scheme of things they’re irrelevant.
0 ¡ Reply
jackedmund99
jackedmund99 May. 5 at 5:48 PM
$IMDX huge volume yesterday whoever’s buying is letting it drift down and the little guys get out. Let let it fall. I believe they’ll be back closer to 4 1/4.
0 ¡ Reply
WarrenPsnik
WarrenPsnik May. 5 at 2:23 PM
$IMDX Starter at $4.80 … (25%), long. Will look to add more on weakness (if there is) eyeing closer to $4.20 average
0 ¡ Reply
StockScanners
StockScanners May. 5 at 5:25 AM
$IMDX keep watch if this holds above 4.98
0 ¡ Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:26 AM
$IMDX https://stocks.apple.com/AVpkzXASkQLalf1EDJGT4bg
0 ¡ Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:20 AM
$IMDX steady now, lads
0 ¡ Reply
topstockalerts
topstockalerts May. 4 at 8:31 PM
$IMDX this is quietly putting in work while everything else chops
0 ¡ Reply
RETAlerts
RETAlerts May. 4 at 8:29 PM
Interesting timing on $IMDX. HVAC content strategy gaining traction, catalyst driving the move. +5.2% on real engagement metric...
0 ¡ Reply
Latest News on IMDX
Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 11 hours ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026


iMDx to Release First Quarter 2026 Results on May 13, 2026

May 6, 2026, 4:05 PM EDT - 7 days ago

iMDx to Release First Quarter 2026 Results on May 13, 2026


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 6 weeks ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025


iMDx Announces $26.0 Million Registered Direct Offering

Feb 11, 2026, 8:00 AM EST - 3 months ago

iMDx Announces $26.0 Million Registered Direct Offering


iMDx prepares for U.S. commercial launch of GraftAssureDx

2026-01-05T12:11:39.000Z - 4 months ago

iMDx prepares for U.S. commercial launch of GraftAssureDx


Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025

Nov 10, 2025, 5:00 PM EST - 6 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025


Insight Molecular Diagnostics announces novel registry database

2025-09-08T11:25:06.000Z - 8 months ago

Insight Molecular Diagnostics announces novel registry database


Insight Molecular Diagnostics Transcript: KOL event

Aug 15, 2025, 4:00 PM EDT - 9 months ago

Insight Molecular Diagnostics Transcript: KOL event


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 9 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025


Oncocyte Reports Q1 2025 Results and Business Progress

May 12, 2025, 4:05 PM EDT - 1 year ago

Oncocyte Reports Q1 2025 Results and Business Progress


Oncocyte Provides Positive Update on Clinical Trial Progress

Apr 30, 2025, 8:30 AM EDT - 1 year ago

Oncocyte Provides Positive Update on Clinical Trial Progress


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024


Oncocyte Reports First Quarter 2024 Financial Results

May 15, 2024, 4:05 PM EDT - 2 years ago

Oncocyte Reports First Quarter 2024 Financial Results


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023


Oncocyte Reports Full Year 2023 Financial Results

Apr 12, 2024, 6:00 AM EDT - 2 years ago

Oncocyte Reports Full Year 2023 Financial Results


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023

Aug 10, 2023, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023


Oncocyte Announces 1-For-20 Reverse Stock Split

Jul 24, 2023, 1:35 PM EDT - 3 years ago

Oncocyte Announces 1-For-20 Reverse Stock Split


Oncocyte Begins Manufacturing Transplant Blood Test

Jun 27, 2023, 8:30 AM EDT - 3 years ago

Oncocyte Begins Manufacturing Transplant Blood Test


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023

May 11, 2023, 9:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023


Oncocyte Reports First Quarter 2023 Financial Results

May 11, 2023, 8:00 AM EDT - 3 years ago

Oncocyte Reports First Quarter 2023 Financial Results


Oncocyte To Announce First Quarter 2023 Financial Results

Apr 27, 2023, 4:59 PM EDT - 3 years ago

Oncocyte To Announce First Quarter 2023 Financial Results


Oncocyte Presents New Data at AACR

Apr 18, 2023, 8:45 AM EDT - 3 years ago

Oncocyte Presents New Data at AACR


Oncocyte Announces Reduction in Force

Apr 12, 2023, 4:15 PM EDT - 3 years ago

Oncocyte Announces Reduction in Force


Bogwood
Bogwood May. 14 at 3:34 AM
$IMDX Not a single IQ sale this past Q 🤢🤮 At least the letter highlights that 2Q will be great, but wow we need to hope the FDA can keep the August date
0 ¡ Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 9:26 PM
$IMDX Q1 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. anticipates continued operating losses and negative operating cash flows for the foreseeable future, though management believes it has sufficient cash to meet projected operating requirements for at least the next twelve months.
0 ¡ Reply
jackedmund99
jackedmund99 May. 5 at 5:52 PM
$IMDX Refinitiv/Verus is a high-performing, quantitative independent research firm- this clown firm put a sale on Stock yesterday while it was going up a dollar it’s a quantitative research company. They have no foresight no intuition. They look at everything from quantitative analytical viewpoint obviously not doing a deep dive not talking to anybody just purely odd numbers so in the grand scheme of things they’re irrelevant.
0 ¡ Reply
jackedmund99
jackedmund99 May. 5 at 5:48 PM
$IMDX huge volume yesterday whoever’s buying is letting it drift down and the little guys get out. Let let it fall. I believe they’ll be back closer to 4 1/4.
0 ¡ Reply
WarrenPsnik
WarrenPsnik May. 5 at 2:23 PM
$IMDX Starter at $4.80 … (25%), long. Will look to add more on weakness (if there is) eyeing closer to $4.20 average
0 ¡ Reply
StockScanners
StockScanners May. 5 at 5:25 AM
$IMDX keep watch if this holds above 4.98
0 ¡ Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:26 AM
$IMDX https://stocks.apple.com/AVpkzXASkQLalf1EDJGT4bg
0 ¡ Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:20 AM
$IMDX steady now, lads
0 ¡ Reply
topstockalerts
topstockalerts May. 4 at 8:31 PM
$IMDX this is quietly putting in work while everything else chops
0 ¡ Reply
RETAlerts
RETAlerts May. 4 at 8:29 PM
Interesting timing on $IMDX. HVAC content strategy gaining traction, catalyst driving the move. +5.2% on real engagement metric...
0 ¡ Reply
Bogwood
Bogwood May. 4 at 8:16 PM
$IMDX such a solid close!! Highest vol since the times square rebranding day
0 ¡ Reply
Logic102
Logic102 May. 4 at 4:07 PM
$IMDX There seems to be a Whale or two quite willing to pay over 20% above an already bolstered up recent share price from today's open after a large Insider Buy recently. Connect the dots.
0 ¡ Reply
ChipDistribution7
ChipDistribution7 May. 4 at 3:55 PM
$IMDX ~$3.8, ~$135M mcap, now a catalyst-driven reset setup rather than a broken biotech. Broadwood (~40%) keeps adding even above prior $5.75 raise levels — usually a strong signal of long-horizon conviction into Q3 2026 regulatory window. Core shift: transplant rejection monitoring moving from invasive biopsies → blood-based donor DNA testing. Science is largely validated, now it’s execution + adoption. Key edge is distribution: kit-based model embedded into existing Bio-Rad ($BIO) PCR infrastructure across hospitals, not centralized labs. <150 days to major catalyst. Approval odds ~70% on diagnostic pathway. If adoption hits → asymmetric rerating (3–10x potential). If not → it stays a delayed turnaround story. Follow me 👉@ChipDistribution7 for real-time updates and everything. Let’s make moves!
0 ¡ Reply
jackedmund99
jackedmund99 May. 4 at 3:27 PM
$IMDX 670,000 shares whose buying ?
1 ¡ Reply
SmartMoneyTradez
SmartMoneyTradez May. 4 at 3:12 PM
$IMDX 50 ma cross
1 ¡ Reply
Logic102
Logic102 May. 4 at 2:49 PM
$IMDX Wow, looking extremely strong the last several days. Anything new today?
0 ¡ Reply
Bogwood
Bogwood May. 3 at 6:29 AM
$IMDX I think we're going to see a surge in IQ sales this upcoming earnings in a couple weeks. Only $30K in lab service sales this Q, but A/R was over $1M as of Dec.
0 ¡ Reply
Bogwood
Bogwood May. 1 at 5:49 AM
$IMDX Over 8M shares traded this month. Others are finally starting to see the vision... 🤩💹🧬📦
0 ¡ Reply
BillionerOfKing
BillionerOfKing Apr. 30 at 3:31 PM
$IMDX Current Stock Price: $3.97 Contracts to trade: $4.0 IMDX May 15 2026 Call Entry: $0.76 Exit: $1.13 ROI: 49% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 ¡ Reply
jackedmund99
jackedmund99 Apr. 29 at 1:03 AM
$IMDX reality Broadwood cap And Neil Bradshear on close to 40% of the company entirely that’s more than 10% 
0 ¡ Reply
Bogwood
Bogwood Apr. 28 at 8:24 PM
$IMDX Look at this pivot guys!!!! Incumbant $CDNA CareDx last week sold off their HLA/ddcf-DNA kit biz, and then used that cash to buy another MRD/cancer diag biz. They've all but folded their transplant hand accepting they're checkmated when it comes to GraftAssure in '27 https://investors.caredx.com/news/news-details/2026/CareDx-Announces-Agreement-to-Acquire-Naveris-A-Leader-in-Viral-Mediated-Cancer-MRD-Surveillance-Testing/default.aspx
0 ¡ Reply
G101SPM
G101SPM Apr. 28 at 2:30 PM
#INSIDERS $EFOR Chief Financial Officer and three (3) Directors bought 13,218 shares combined worth approximately $260K (transaction dates were 4/27). $IMDX 10% owner Broadwood Partners bought 570,184 shares at $3.39 - $3.84 worth approximately $2.0 mln (transaction dates 4/23-4/27). $KREF Chief Executive Officer and the President, COO and Secretary bought 100,000 shares combined at $5.99 - $6.09 worth approximately $604K (transaction dates were 4/24). $WASH Senior Executive Vice President and Chief Commercial Banking bought 32,000 shares at $30.42 - $31.57 worth approximately $998K (transaction date 4/23).
0 ¡ Reply